Price movement over the last 24 hours
Bank Capital Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Capital Indonesia Tbk trades at Rp101 (market cap 2.03T, 1.66M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank Capital Indonesia Tbk is far larger — about 12.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Capital Indonesia Tbk is more actively traded (1.66M versus 214.9K). Which is the better fit depends on your goals.
| BACA | OBAT | |
|---|---|---|
Market Cap | 2.03T | 164.65B |
Volume | 1.66M | 214.9K |
Lot | 16.61K | 2.15K |
Turnover | 166.37M | 51.97M |
Average Price | 100.17 | 241.85 |
Value | 166.37M | 51.97M |
Indicative Equilibrium Price | 101 | 240 |
Indicative Equilibrium Volume | 20 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Capital Indonesia (the company) was established under its original name of PT Bank Credit Lyonnais base on notarial deed No.139 of Mrs Siti Pertiwi, S.H, dated on Apr 20, 1989. The Company's articles of association has been amended several times, most recently by notarial deed No. 60 of Eliwati Tjitra, S.H., dated Jul 17, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering.
Read more on BACA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →